Mendus reports complete enrollment of the first stage of the VITAL-CML trial
Keep reading
Mendus announces collaboration with the South Australian Health and Medical Research Institute (SAHMRI) to support preparation of the VITAL-TFR2 trial in chronic myeloid leukemia (CML)
